Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
February-2022 Volume 25 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2022 Volume 25 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation

  • Authors:
    • Yingting Wu
    • Feilong Zhu
    • Wenqin Sun
    • Weiwei Shen
    • Qin Zhang
    • Huifen Chen
  • View Affiliations / Copyright

    Affiliations: Department of Laboratory Medicine, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200092, P.R. China, Phase I Clinical Trial Unit, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
    Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 56
    |
    Published online on: December 15, 2021
       https://doi.org/10.3892/mmr.2021.12573
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Endometriosis (EM), the presence of functional endometrial glands and stroma outside the uterine cavity, is a common gynecological disorder. At present, the pathogenesis of EM has not been fully elucidated, so there is still a lack of effective therapy. The present study aimed to explore the role of C‑C motif chemokine ligand 28 (CCL28) and its underlying mechanism in endometrial stromal cells to propose a novel therapy for EM treatment. The expression of CCL28 and CC chemokine receptor 10 (CCR10) were examined. After CCL28 knockdown or overexpression by lentivirus infection, cell proliferation and invasion were measured. It was revealed that compared with normal, the expression levels of CCL28 and CCR10 were significantly elevated in endometrial tissues of patients with EM. Knockdown of CCL28 in endometrial stromal cells significantly suppressed cell proliferation and invasion, and this was accompanied by significantly reduced expression levels of CCR10, MMP2, MMP9, integrin β1 (ITGB1) and phosphorylated (p)‑ERK/ERK ratio. The addition of the CCL28 recombinant protein had an opposite effect to CCL28 downregulation. Furthermore, the ERK inhibitor, PD98059, reduced CCL28‑induced cell proliferation and invasion, as well as the expression levels of MMP2, MMP9, ITGB1 and p‑ERK. Therefore, the present study indicated that CCL28 may contribute to the progression of EM by regulating MMP2, MMP9 and ITGB1 expression and function via the activation of the ERK signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A and Saridogan E; ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group, : ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 20:2698–2704. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Eskenazi B and Warner ML: Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 24:235–258. 1997. View Article : Google Scholar : PubMed/NCBI

3 

Zondervan KT, Yudkin PL, Vessey MP, Jenkinson CP, Dawes MG, Barlow DH and Kennedy SH: The community prevalence of chronic pelvic pain in women and associated illness behaviour. Br J Gen Pract. 51:541–547. 2001.PubMed/NCBI

4 

Zondervan KT, Cardon LR and Kennedy SH: What makes a good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod. 17:1415–1423. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Rogers PA, D'Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW, Rombauts L, Salamonsen LA and Zondervan KT: Priorities for endometriosis research: Recommendations from an international consensus workshop. Reprod Sci. 16:335–346. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Rolla E: Endometriosis: Advances and controversies in classification, pathogenesis, diagnosis, and treatment. F1000 Res. 8:82019. View Article : Google Scholar : PubMed/NCBI

7 

Liu J, Wang Y, Chen P, Ma Y, Wang S, Tian Y, Wang A and Wang D: AC002454.1 and CDK6 synergistically promote endometrial cell migration and invasion in endometriosis. Reproduction. 157:535–543. 2019. View Article : Google Scholar : PubMed/NCBI

8 

Bakogiannis C, Sachse M, Stamatelopoulos K and Stellos K: Platelet-derived chemokines in inflammation and atherosclerosis. Cytokine. 122:1541572019. View Article : Google Scholar : PubMed/NCBI

9 

Korbecki J, Grochans S, Gutowska I, Barczak K and Baranowska-Bosiacka I: CC Chemokines in a tumor: A review of pro-cancer and anti-cancer properties of receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 ligands. Int J Mol Sci. 21:212020. View Article : Google Scholar

10 

Bian X, Xiao YT, Wu T, Yao M, Du L, Ren S and Wang J: Microvesicles and chemokines in tumor microenvironment: Mediators of intercellular communications in tumor progression. Mol Cancer. 18:502019. View Article : Google Scholar : PubMed/NCBI

11 

Hieshima K, Ohtani H, Shibano M, Izawa D, Nakayama T, Kawasaki Y, Shiba F, Shiota M, Katou F, Saito T, et al: CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J Immunol. 170:1452–1461. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Berri M, Virlogeux-Payant I, Chevaleyre C, Melo S, Zanello G, Salmon H and Meurens F: CCL28 involvement in mucosal tissues protection as a chemokine and as an antibacterial peptide. Dev Comp Immunol. 44:286–290. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Moed H, Boorsma DM, Tensen CP, Flier J, Jonker MJ, Stoof TJ, von Blomberg BM, Bruynzeel DP, Scheper RJ, Rustemeyer T, et al: Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory. Journal Pathol. 204:39–46. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Chen L, Liu X, Zhang H-Y, Du W, Qin Z, Yao Y, Mao Y and Zhou L: Upregulation of chemokine receptor CCR10 is essential for glioma proliferation, invasion and patient survival. Oncotarget. 5:6576–6583. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Xiong N, Fu Y, Hu S, Xia M and Yang J: CCR10 and its ligands in regulation of epithelial immunity and diseases. Protein Cell. 3:571–580. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Lin HY, Sun SM, Lu XF, Chen PY, Chen CF, Liang WQ and Peng CY: CCR10 activation stimulates the invasion and migration of breast cancer cells through the ERK1/2/MMP-7 signaling pathway. Int Immunopharmacol. 51:124–130. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Ruan F, Ma J and Zhou J: Depletion of CCL27 inhibits cell proliferation, metastasis and adhesion in ectopic endometrial stromal cells. Int J Clin Exp Med. 9:19074–19083. 2016.

18 

Sun C, Zhang YY, Tang CL, Wang SC, Piao HL, Tao Y, Zhu R, Du MR and Li DJ: Chemokine CCL28 induces apoptosis of decidual stromal cells via binding CCR3/CCR10 in human spontaneous abortion. Mol Hum Reprod. 19:676–686. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Cha HR, Ko HJ, Kim ED, Chang SY, Seo SU, Cuburu N, Ryu S, Kim S and Kweon MN: Mucosa-associated epithelial chemokine/CCL28 expression in the uterus attracts CCR10+ IgA plasma cells following mucosal vaccination via estrogen control. J Immunol. 187:3044–3052. 2011. View Article : Google Scholar : PubMed/NCBI

20 

Gentilini D, Busacca M, Di Francesco S, Vignali M, Viganò P and Di Blasio AM: PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17β-estradiol and growth factors. Mol Hum Reprod. 13:317–322. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Tong JS, Zhang QH, Huang X, Fu XQ, Qi ST, Wang YP, Hou Y, Sheng J and Sun QY: Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells. PLoS One. 6:e167812011. View Article : Google Scholar : PubMed/NCBI

22 

Banu SK, Lee J, Speights VO Jr, Starzinski-Powitz A and Arosh JA: Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and β-catenin pathways and activation of intrinsic apoptotic mechanisms. Mol Endocrinol. 23:1291–1305. 2009. View Article : Google Scholar : PubMed/NCBI

23 

Li MQ, Li HP, Meng YH, Wang Zhu XY, Mei J and Li DJ: Chemokine CCL2 enhances survival and invasiveness of endometrial stromal cells in an autocrine manner by activating Akt and MAPK/Erk1/2 signal pathway. Fertil Steril. 97:919–929. 2012. View Article : Google Scholar : PubMed/NCBI

24 

Li MQ, Shao J, Meng YH, Mei J, Wang Y, Li H, Zhang L, Chang KK, Wang XQ, Zhu XY, et al: NME1 suppression promotes growth, adhesion and implantation of endometrial stromal cells via Akt and MAPK/Erk1/2 signal pathways in the endometriotic milieu. Hum Reprod. 28:2822–2831. 2013. View Article : Google Scholar : PubMed/NCBI

25 

Yang XL, Liu KY, Lin FJ, Shi HM and Ou ZL: CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis. Oncol Rep. 38:1393–1401. 2017. View Article : Google Scholar : PubMed/NCBI

26 

Liu J, Zhang Z, Liu J and Wang D: LIM Kinase 1 Mediates estradiol effects on the phosphorylation of Cofilin1 in eutopic endometrial stromal cells during the invasion and proliferation of endometriosis. Reprod Sci. 26:1499–1505. 2019. View Article : Google Scholar : PubMed/NCBI

27 

Chen Q, Hang Y, Zhang T, Tan L, Li S and Jin Y: USP10 promotes proliferation and migration and inhibits apoptosis of endometrial stromal cells in endometriosis through activating the Raf-1/MEK/ERK pathway. Am J Physiol Cell Physiol. 315:C863–C872. 2018. View Article : Google Scholar : PubMed/NCBI

28 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

29 

Minkwitz C, Schoon HA, Zhang Q and Schöniger S: Plasticity of endometrial epithelial and stromal cells-A new approach towards the pathogenesis of equine endometrosis. Reprod Domest Anim. 54:835–845. 2019. View Article : Google Scholar : PubMed/NCBI

30 

Deng X, Zhang X, Li W, Feng RX, Li L, Yi GR, Zhang XN, Yin C, Yu HY, Zhang JP, et al: Chronic Liver Injury Induces Conversion of Biliary Epithelial Cells into Hepatocytes. Cell Stem Cell. 23:114–122.e3. 2018. View Article : Google Scholar : PubMed/NCBI

31 

Gou Y, Li X, Li P, Zhang H, Xu T, Wang H, Wang B, Ma X, Jiang X and Zhang Z: Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis. Hum Reprod. 34:646–658. 2019. View Article : Google Scholar : PubMed/NCBI

32 

Mei J, Zhou WJ, Li SY, Li MQ and Sun HX: Interleukin-22 secreted by ectopic endometrial stromal cells and natural killer cells promotes the recruitment of macrophages through promoting CCL2 secretion. Am J Reprod Immunol. 82:e131662019. View Article : Google Scholar : PubMed/NCBI

33 

Hirata T, Osuga Y, Takamura M, Kodama A, Hirota Y, Koga K, Yoshino O, Harada M, Takemura Y, Yano T, et al: Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from IL-1 β-, TNF-α-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology. 151:5468–5476. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Guo P, Bi K, Lu Z, Wang K, Xu Y, Wu H, Cao Y and Jiang H: CCR5/CCR5 ligand-induced myeloid-derived suppressor cells are related to the progression of endometriosis. Reprod Biomed Online. 39:704–711. 2019. View Article : Google Scholar : PubMed/NCBI

35 

Jaiswal U, Yadav RK, Bhat MA, Kriplani A, Roy KK and Netam RK: Cytokine and growth factor profile in endometriosis: a multiplex analysis of peritoneal fluid to assess diagnostic utility. Gynecol Endocrinol. 36:718–722. 2020. View Article : Google Scholar : PubMed/NCBI

36 

Rashidiani S, Jalili A, Babaei E, Sheikhesmaeili F, Fakhari S, Ataee P and Parhizkar B: The chemokine CCL28 is elevated in the serum of patients with celiac disease and decreased after treatment. Am J Clin Exp Immunol. 6:60–65. 2017.PubMed/NCBI

37 

Sanaei MJ, Shirzad H, Soltani A, Abdollahpour-Alitappeh M, Shafigh MH, Rahimian G, Mirzaei Y and Bagheri N: Up-regulated CCL18, CCL28 and CXCL13 expression is associated with the risk of gastritis and peptic ulcer disease in Helicobacter pylori infection. Am J Med Sci. 361:43–54. 2021. View Article : Google Scholar : PubMed/NCBI

38 

Lv Y, Zhao X, Zhu L, Li S, Xiao Q, He W and Yin L: Targeting intracellular MMPs efficiently inhibits tumor metastasis and angiogenesis. Theranostics. 8:2830–2845. 2018. View Article : Google Scholar : PubMed/NCBI

39 

Wang X, Yang B, She Y and Ye Y: The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9. J Cell Biochem. 119:7790–7799. 2018. View Article : Google Scholar : PubMed/NCBI

40 

Farina P, Tabouret E, Lehmann P, Barrie M, Petrirena G, Campello C, Boucard C, Graillon T, Girard N and Chinot O: Relationship between magnetic resonance imaging characteristics and plasmatic levels of MMP2 and MMP9 in patients with recurrent high-grade gliomas treated by Bevacizumab and Irinotecan. J Neurooncol. 132:433–437. 2017. View Article : Google Scholar : PubMed/NCBI

41 

Pino M, Galleguillos C, Torres M, Sovino H, Fuentes A, Boric MA and Johnson MC: Association between MMP1 and MMP9 activities and ICAM1 cleavage induced by TNF in stromal cell cultures from eutopic endometria of women with endometriosis. Reproduction. 138:837–847. 2009. View Article : Google Scholar : PubMed/NCBI

42 

Aglund K, Rauvala M, Puistola U, Angström T, Turpeenniemi-Hujanen T, Zackrisson B and Stendahl U: Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol Oncol. 94:699–704. 2004. View Article : Google Scholar : PubMed/NCBI

43 

Honkavuori M, Talvensaari-Mattila A, Soini Y, Turpeenniemi-Hujanen T and Santala M: MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma. Gynecol Oncol. 104:217–221. 2007. View Article : Google Scholar : PubMed/NCBI

44 

Barbe AM, Berbets AM, Davydenko IS, Koval HD, Yuzko VO and Yuzko OM: Expression and significance of matrix metalloproteinase-2 and matrix metalloproteinas-9 in Endometriosis. J Med Life. 13:314–320. 2020.PubMed/NCBI

45 

Freitas S, Meduri G, Le Nestour E, Bausero P and Perrot-Applanat M: Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol Reprod. 61:1070–1082. 1999. View Article : Google Scholar : PubMed/NCBI

46 

Yoshiji H, Harris SR, Raso E, Gomez DE, Lindsay CK, Shibuya M, Sinha CC and Thorgeirsson UP: Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression. Int J Cancer. 75:81–87. 1998. View Article : Google Scholar : PubMed/NCBI

47 

Kodarahmian M, Amidi F, Moini A, Kashani L, Nashtaei MS, Pazhohan A, Bahramrezai M, Berenjian S and Sobhani A: The modulating effects of resveratrol on the expression of MMP-2 and MMP-9 in endometriosis women: A randomized exploratory trial. Gynecol Endocrinol. 35:719–726. 2019. View Article : Google Scholar : PubMed/NCBI

48 

Shan B, Li W, Yang SY and Li ZR: Estrogen up-regulates MMP2/9 expression in endometrial epithelial cell via VEGF-ERK1/2 pathway. Asian Pac J Trop Med. 6:826–830. 2013. View Article : Google Scholar : PubMed/NCBI

49 

Wang D, Wang D, Wang N, Long Z and Ren X: Long non-coding RNA BANCR promotes endometrial cancer cell proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK signaling pathway. Cell Physiol Biochem. 40:644–656. 2016. View Article : Google Scholar : PubMed/NCBI

50 

Lei Y, Huang K, Gao C, Lau QC, Pan H, Xie K, Li J, Liu R, Zhang T, Xie N, et al: Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells. Mol Cell Proteomics. May 27–2011.(Epub ahead of print). doi: 10.1074/mcp.M110.005397. View Article : Google Scholar

51 

Chen J, Gu L, Ni J, Hu P, Hu K and Shi YL: MiR-183 regulates ITGB1P expression and promotes invasion of endometrial stromal cells. Biomed Res Int. 2015:3402182015.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wu Y, Zhu F, Sun W, Shen W, Zhang Q and Chen H: Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation. Mol Med Rep 25: 56, 2022.
APA
Wu, Y., Zhu, F., Sun, W., Shen, W., Zhang, Q., & Chen, H. (2022). Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation. Molecular Medicine Reports, 25, 56. https://doi.org/10.3892/mmr.2021.12573
MLA
Wu, Y., Zhu, F., Sun, W., Shen, W., Zhang, Q., Chen, H."Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation". Molecular Medicine Reports 25.2 (2022): 56.
Chicago
Wu, Y., Zhu, F., Sun, W., Shen, W., Zhang, Q., Chen, H."Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation". Molecular Medicine Reports 25, no. 2 (2022): 56. https://doi.org/10.3892/mmr.2021.12573
Copy and paste a formatted citation
x
Spandidos Publications style
Wu Y, Zhu F, Sun W, Shen W, Zhang Q and Chen H: Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation. Mol Med Rep 25: 56, 2022.
APA
Wu, Y., Zhu, F., Sun, W., Shen, W., Zhang, Q., & Chen, H. (2022). Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation. Molecular Medicine Reports, 25, 56. https://doi.org/10.3892/mmr.2021.12573
MLA
Wu, Y., Zhu, F., Sun, W., Shen, W., Zhang, Q., Chen, H."Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation". Molecular Medicine Reports 25.2 (2022): 56.
Chicago
Wu, Y., Zhu, F., Sun, W., Shen, W., Zhang, Q., Chen, H."Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation". Molecular Medicine Reports 25, no. 2 (2022): 56. https://doi.org/10.3892/mmr.2021.12573
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team